Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
Argentina, CEO, Colombia, doubt, Factor, immunological, midyear, mission, OS, Peru, postponing, RECIST, repertoire, robust, screening, tract, urinary, UroGen, Venezuela, workforce
Removed:
body, capital, core, discontinue, Gastrointestinal, historically, immune, reduce, restrict, scale, speed, successful
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view